Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.

Six new doctoral (PhD or DPhil) places are being created through the shared initiative to lead antimicrobial research teams. Antimicrobial resistance – when microbes, such as bacteria and viruses, outwit our medicines and cause untreatable infections – is already a huge and growing health problem around the world. By 2050 it is estimated that there will be around 10 million global deaths related to drug resistant infections, overtaking the number of cancer related deaths.

Founded at the University of Oxford in 2021, the Ineos Oxford Institute (IOI) was established to tackle this pressing global challenge. It is based at the Sir William Dunn School of Pathology in Oxford, where penicillin was first developed into a viable drug.

The successful candidates will be fully funded for three and a half years.

Professor Chris Schofield, Head of Chemistry at the Ineos Oxford Institute, said: “This new doctoral initiative represents an exciting step towards training the brightest talent to help combat antimicrobial resistance. The first doctoral initiative of its kind in the field, it shows the commitment of both of these leading universities to collaborate on tackling one of the world’s most urgent medical problems.”

Read the full story on the University of Oxford website. 

Similar stories

Student Prizes for Biomedical Sciences and Medicine 2021-2022

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2021-2022 academic year.

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Researchers discover novel form of adaptation in the auditory system

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have found that the auditory system adapts to the changing acoustics of reverberant environments by temporally shifting the inhibitory tuning of cortical neurons to remove reverberation.

20 minutes of daily exercise can keep teens' doctors away

Teenagers should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the UK led by University of Oxford researchers.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.